ID

34226

Beschrijving

The Impact of the Routine Aminophylline Administration Following Regadenoson Stress on SPECT Myocardial Perfusion; ODM derived from: https://clinicaltrials.gov/show/NCT01655524

Link

https://clinicaltrials.gov/show/NCT01655524

Trefwoorden

  1. 15-01-19 15-01-19 -
Houder van rechten

see on clinicaltrials.gov

Geüploaded op

15 januari 2019

DOI

Voor een aanvraag inloggen.

Licentie

Creative Commons BY 4.0

Model Commentaren :

Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.

Itemgroep Commentaren voor :

Item Commentaren voor :

U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.

Eligibility Coronary Artery Disease NCT01655524

Eligibility Coronary Artery Disease NCT01655524

Inclusion Criteria
Beschrijving

Inclusion Criteria

Alias
UMLS CUI
C1512693
patients who have had a qualifying regadenoson stress myocardial perfusion imaging (regadenoson nuclear stress test).
Beschrijving

ID.1

Datatype

boolean

Exclusion Criteria
Beschrijving

Exclusion Criteria

Alias
UMLS CUI
C0680251
inability to provide an informed consent
Beschrijving

ID.2

Datatype

boolean

known allergic reaction to aminophylline or regadenoson
Beschrijving

ID.3

Datatype

boolean

systolic blood pressure < 90 mmhg
Beschrijving

ID.4

Datatype

boolean

unstable abnormal heart rhythm
Beschrijving

ID.5

Datatype

boolean

pulmonary edema
Beschrijving

ID.6

Datatype

boolean

acute coronary symptoms, myocardial infarction within 48 hours
Beschrijving

ID.7

Datatype

boolean

active dipyridamole, aminophylline or theophylline use
Beschrijving

ID.8

Datatype

boolean

pregnancy
Beschrijving

ID.9

Datatype

boolean

any contraindication to aminophylline according to the drug's package insert: uncontrolled seizure disorder, sepsis with multi-organ failure and liver impairment
Beschrijving

ID.10

Datatype

boolean

Similar models

Eligibility Coronary Artery Disease NCT01655524

Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Item Group
C1512693 (UMLS CUI)
ID.1
Item
patients who have had a qualifying regadenoson stress myocardial perfusion imaging (regadenoson nuclear stress test).
boolean
Item Group
C0680251 (UMLS CUI)
ID.2
Item
inability to provide an informed consent
boolean
ID.3
Item
known allergic reaction to aminophylline or regadenoson
boolean
ID.4
Item
systolic blood pressure < 90 mmhg
boolean
ID.5
Item
unstable abnormal heart rhythm
boolean
ID.6
Item
pulmonary edema
boolean
ID.7
Item
acute coronary symptoms, myocardial infarction within 48 hours
boolean
ID.8
Item
active dipyridamole, aminophylline or theophylline use
boolean
ID.9
Item
pregnancy
boolean
ID.10
Item
any contraindication to aminophylline according to the drug's package insert: uncontrolled seizure disorder, sepsis with multi-organ failure and liver impairment
boolean

Gebruik dit formulier voor feedback, vragen en verbeteringsvoorstellen.

Velden gemarkeerd met een * zijn verplicht.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial